J. W. A. Meijer - Concepedia

Author

J. W. A. Meijer

Stichting Epilepsie Instellingen Nederland

Also Known As

J Meijer, J W Meijer, J. Meijer, J. W. A. MEIJER, J. W. A. Meijer, J. W. Meijer, J. W.A. Meijer, J.W.A Meijer, J.W.A. Meijer, J. W. A. Meijer

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Stichting Epilepsie Instellingen Nederland Janssen (Belgium)Kempenhaeghe Hewlett-Packard (Germany)Wellcome Trust

About

J. W. A. Meijer is an author at Stichting Epilepsie Instellingen Nederland specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	28	1.3K
2	Engineering	3	3	53
3	Health Sciences	2	2	27
4	Social Sciences	2	2	95
5	Public Health	1	1	73

J. W. A. Meijer

Publications

Citations

H-Index

Page 1

	Year	Citations
Acute Effects of Lamotrigine (BW430C) in Persons With Epilepsy C. D. Binnie, W. van Emde Boas, D. G. A. Kasteleijn‐Nolste‐Trenite, Epilepsia	1986	190
Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy C.D. Binnie, R. M. Chr. Debets, Martijn Engelsman, Epilepsy Research Neuromodulation TherapiesIntractable EpilepsyNeurologyNeuroscienceNeuropathology	1989	173
Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Dick Lindhout, H. Meinardi, J. W. A. Meijer, PubMed Drug SafetyPsychiatryAntiepileptic DrugsPharmacologyPediatrics	1992	159
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures A. James Rowan, J. W. A. Meijer, N. de Beer-Pawlikowski, Archives of Neurology	1983	151
Double‐Blind Placebo‐Controlled Trial of Flunarizine as Add‐on Therapy in Epilepsy J. Overweg, C.D. Binnie, J. W. A. Meijer, Epilepsia	1984	133
Correlation Between Daily Fluctuations of Carbamazepine Serum Levels and Intermittent Side Effects R. J. Höpener, A. Kuyer, J. W. A. Meijer, Epilepsia Intermittent Side EffectsTherapeutic Drug MonitoringPsychiatryMedicinePsychotropic Medication	1980	108
THE METABOLISM OF IODOTYROSINES. II THE METABOLISM OF MONO- AND DI-IODOTYROSINE II CERTAIN PATIENTS WITH FAMILIAL GOITER* John B. Stanbury, J. W. A. Meijer, A. A. H. Kassenaar The Journal of Clinical Endocrinology & Metabolism I131-labeled Dl-di-iodotyrosineMedicineIodine Deficiency DisordersFree Mono-Metabolism Of Iodotyrosines	1956	107
THE OCCURRENCE OF MONO- AND DI-IODOTYROSINE IN THE BLOOD OF A PATIENT WITH CONGENITAL GOITER* John B. Stanbury, A. A. H. Kassenaar, J. W. A. Meijer, The Journal of Clinical Endocrinology & Metabolism Congenital EnlargmentIodine Deficiency DisordersThyroid DiseaseThyroid PowderGynecology	1955	101
THE METABOLISM OF IODOTYROSINES. I. THE FATE OF MONO- AND DI-IODOTYROSINE IN NORMAL SUBJECTS AND IN PATIENTS WITH VARIOUS DISEASES* John B. Stanbury, A. A. H. Kassenaar, J. W. A. Meijer, The Journal of Clinical Endocrinology & Metabolism Peptide LinkageGeneral CirculationBiochemistryMedicineIodine Deficiency Disorders	1956	76
The circadian distribution of interictal epileptiform EEG activity António Martins da Silva, J.H.P Aarts, C. D. Binnie, Electroencephalography and Clinical Neurophysiology Circadian DistributionNeurophysiologyMedicineEeg Signal ProcessingCognitive Electrophysiology	1984	75

Page 1